Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cysteine-type deubiquitinase activity	USP17L21 USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.47e-19	114	120	17	GO:0004843
GeneOntologyMolecularFunction	deubiquitinase activity	USP17L21 USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.09e-18	124	120	17	GO:0101005
GeneOntologyMolecularFunction	ubiquitin-like protein peptidase activity	USP17L21 USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	6.24e-18	137	120	17	GO:0019783
GeneOntologyMolecularFunction	cysteine-type peptidase activity	USP17L21 USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.01e-15	192	120	17	GO:0008234
GeneOntologyMolecularFunction	peptidase activity	USP17L21 USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 PRSS38 USP17L20 USP17L11 MMP23B CPB2 USP17L10 USP17L19 F11 USP17L18 CNTNAP5 MMEL1 MBTPS2 USP17L17 HPN USP17L3 KLK9 USP17L22 USP17L15 USP17L8 USP17L13	1.29e-14	654	120	26	GO:0008233
GeneOntologyMolecularFunction	structural constituent of cytoskeleton	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	1.36e-05	130	120	7	GO:0005200
GeneOntologyMolecularFunction	nicotinic acid receptor activity	HCAR2 HCAR3	3.58e-05	2	120	2	GO:0070553
GeneOntologyMolecularFunction	1-acylglycerophosphoserine O-acyltransferase activity	MBOAT2 LPCAT3	2.13e-04	4	120	2	GO:0106263
GeneOntologyMolecularFunction	1-acylglycerophosphoethanolamine O-acyltransferase activity	MBOAT2 LPCAT3	2.13e-04	4	120	2	GO:0106262
GeneOntologyMolecularFunction	thrombin-activated receptor activity	F2RL1 F2RL2	3.54e-04	5	120	2	GO:0015057
GeneOntologyMolecularFunction	proteinase-activated receptor activity	F2RL1 F2RL2	3.54e-04	5	120	2	GO:0001648
GeneOntologyMolecularFunction	protein kinase A binding	ARFGEF2 ARFGEF1 NBEA LRBA	4.10e-04	58	120	4	GO:0051018
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	MYCBP2 ARFGEF2 ARFGEF1 PLEKHG1 HERC1 MCF2L DNMBP	4.98e-04	231	120	7	GO:0005085
GeneOntologyMolecularFunction	GTP binding	HCAR2 TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B HCAR3 TUBA1A TUBAL3	6.65e-04	397	120	9	GO:0005525
GeneOntologyMolecularFunction	1-acylglycerophosphocholine O-acyltransferase activity	MBOAT2 LPCAT3	9.79e-04	8	120	2	GO:0047184
GeneOntologyMolecularFunction	2-acylglycerol-3-phosphate O-acyltransferase activity	MBOAT2 LPCAT3	1.25e-03	9	120	2	GO:0047144
GeneOntologyMolecularFunction	guanyl ribonucleotide binding	HCAR2 TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B HCAR3 TUBA1A TUBAL3	1.35e-03	439	120	9	GO:0032561
GeneOntologyMolecularFunction	guanyl nucleotide binding	HCAR2 TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B HCAR3 TUBA1A TUBAL3	1.35e-03	439	120	9	GO:0019001
GeneOntologyMolecularFunction	myosin binding	ARFGEF2 ARFGEF1 GSN CXCR4	1.73e-03	85	120	4	GO:0017022
GeneOntologyMolecularFunction	serine-type exopeptidase activity	F11 HPN	2.27e-03	12	120	2	GO:0070008
GeneOntologyBiologicalProcess	protein deubiquitination	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.26e-17	125	120	16	GO:0016579
GeneOntologyBiologicalProcess	protein modification by small protein removal	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.27e-16	144	120	16	GO:0070646
GeneOntologyBiologicalProcess	protein modification by small protein conjugation or removal	USP17L21 USP17L4 ABL1 USP17L2 USP17L12 USP17L1 MYCBP2 USP17L20 USP17L11 UBR4 USP17L10 USP17L19 USP17L18 USP17L17 ASB5 USP17L3 HERC3 HERC1 USP17L22 USP17L15 USP17L8 USP17L13	7.64e-08	1009	120	22	GO:0070647
GeneOntologyBiologicalProcess	post-translational protein modification	USP17L21 USP17L4 ABL1 USP17L2 USP17L12 USP17L1 MYCBP2 USP17L20 USP17L11 UBR4 USP17L10 USP17L19 USP17L18 USP17L17 ASB5 USP17L3 HERC3 HERC1 USP17L22 USP17L15 USP17L8 USP17L13	2.25e-07	1074	120	22	GO:0043687
GeneOntologyCellularComponent	endoplasmic reticulum membrane	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 MPDU1 MMP23B USP17L10 USP17L19 CYP46A1 MBOAT2 EPM2AIP1 USP17L18 MBTPS2 MGST2 USP17L17 HPN LPCAT3 TM7SF2 USP17L3 FLRT1 LRBA USP17L22 USP17L15 MAN1B1 USP17L8 USP17L13	1.54e-10	1293	120	29	GO:0005789
GeneOntologyCellularComponent	endoplasmic reticulum subcompartment	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 MPDU1 MMP23B USP17L10 USP17L19 CYP46A1 MBOAT2 EPM2AIP1 USP17L18 MBTPS2 MGST2 USP17L17 HPN LPCAT3 TM7SF2 USP17L3 FLRT1 LRBA USP17L22 USP17L15 MAN1B1 USP17L8 USP17L13	1.72e-10	1299	120	29	GO:0098827
GeneOntologyCellularComponent	nuclear outer membrane-endoplasmic reticulum membrane network	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 MPDU1 MMP23B USP17L10 USP17L19 CYP46A1 MBOAT2 EPM2AIP1 USP17L18 MBTPS2 MGST2 USP17L17 HPN LPCAT3 TM7SF2 USP17L3 FLRT1 LRBA USP17L22 USP17L15 MAN1B1 USP17L8 USP17L13	2.84e-10	1327	120	29	GO:0042175
GeneOntologyCellularComponent	microtubule	TUBA3D TUBA1C ARFGEF2 TUBA3E TUBA3C TUBA1B TUBA1A DNAH6 DNAH8 TUBAL3 INVS	2.53e-04	533	120	11	GO:0005874
MousePheno	increased trophectoderm apoptosis	USP17L2 USP17L15 USP17L13	1.37e-05	8	89	3	MP:0012119
Domain	HABP4_PAI-RBP1	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13	1.69e-21	16	118	11	PF04774
Domain	HABP4_PAIRBP1-bd	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13	1.69e-21	16	118	11	IPR006861
Domain	UCH	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	2.77e-19	71	118	15	PF00443
Domain	USP_2	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	2.77e-19	71	118	15	PS00973
Domain	USP_3	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	3.48e-19	72	118	15	PS50235
Domain	USP_dom	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	3.48e-19	72	118	15	IPR028889
Domain	Peptidase_C19_UCH	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	3.48e-19	72	118	15	IPR001394
Domain	USP_CS	USP17L21 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	4.29e-18	66	118	14	IPR018200
Domain	USP_1	USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	1.05e-17	70	118	14	PS00972
Domain	Alpha_tubulin	TUBA3D TUBA1C TUBA3E TUBA1B TUBA1A TUBAL3	4.63e-12	9	118	6	IPR002452
Domain	-	TUBA3D TUBA1C TUBA3E TUBA1B TUBA1A TUBAL3	2.02e-09	20	118	6	3.30.1330.20
Domain	-	TUBA3D TUBA1C TUBA3E TUBA1B TUBA1A TUBAL3	2.81e-09	21	118	6	1.10.287.600
Domain	Tubulin_C	TUBA3D TUBA1C TUBA3E TUBA1B TUBA1A TUBAL3	3.84e-09	22	118	6	SM00865
Domain	Tubulin_C	TUBA3D TUBA1C TUBA3E TUBA1B TUBA1A TUBAL3	3.84e-09	22	118	6	PF03953
Domain	Tubulin/FtsZ_2-layer-sand-dom	TUBA3D TUBA1C TUBA3E TUBA1B TUBA1A TUBAL3	3.84e-09	22	118	6	IPR018316
Domain	-	TUBA3D TUBA1C TUBA3E TUBA1B TUBA1A TUBAL3	3.84e-09	22	118	6	3.40.50.1440
Domain	Tubulin_C	TUBA3D TUBA1C TUBA3E TUBA1B TUBA1A TUBAL3	5.17e-09	23	118	6	IPR023123
Domain	TUBULIN	TUBA3D TUBA1C TUBA3E TUBA1B TUBA1A TUBAL3	5.17e-09	23	118	6	PS00227
Domain	Tubulin	TUBA3D TUBA1C TUBA3E TUBA1B TUBA1A TUBAL3	5.17e-09	23	118	6	IPR000217
Domain	Tub_FtsZ_C	TUBA3D TUBA1C TUBA3E TUBA1B TUBA1A TUBAL3	5.17e-09	23	118	6	IPR008280
Domain	Tubulin	TUBA3D TUBA1C TUBA3E TUBA1B TUBA1A TUBAL3	5.17e-09	23	118	6	SM00864
Domain	Tubulin_CS	TUBA3D TUBA1C TUBA3E TUBA1B TUBA1A TUBAL3	5.17e-09	23	118	6	IPR017975
Domain	Tubulin_FtsZ_GTPase	TUBA3D TUBA1C TUBA3E TUBA1B TUBA1A TUBAL3	6.86e-09	24	118	6	IPR003008
Domain	Tubulin	TUBA3D TUBA1C TUBA3E TUBA1B TUBA1A TUBAL3	6.86e-09	24	118	6	PF00091
Domain	DUF1088	NBEA LRBA	3.96e-05	2	118	2	IPR010508
Domain	HCAR2/3_rcpt	HCAR2 HCAR3	3.96e-05	2	118	2	IPR028017
Domain	DUF1088	NBEA LRBA	3.96e-05	2	118	2	PF06469
Domain	DUF1981	ARFGEF2 ARFGEF1	2.36e-04	4	118	2	PF09324
Domain	Protea_act_rcpt	F2RL1 F2RL2	2.36e-04	4	118	2	IPR003912
Domain	Sec7_N	ARFGEF2 ARFGEF1	2.36e-04	4	118	2	IPR032691
Domain	Sec7_N	ARFGEF2 ARFGEF1	2.36e-04	4	118	2	PF12783
Domain	DCB_dom	ARFGEF2 ARFGEF1	2.36e-04	4	118	2	IPR032629
Domain	DCB	ARFGEF2 ARFGEF1	2.36e-04	4	118	2	PF16213
Domain	Sec7_C	ARFGEF2 ARFGEF1	2.36e-04	4	118	2	IPR015403
Domain	RCC1	MYCBP2 HERC3 HERC1	2.59e-04	20	118	3	PF00415
Domain	RCC1_1	MYCBP2 HERC3 HERC1	3.01e-04	21	118	3	PS00625
Domain	RCC1_2	MYCBP2 HERC3 HERC1	3.01e-04	21	118	3	PS00626
Domain	RCC1_3	MYCBP2 HERC3 HERC1	3.01e-04	21	118	3	PS50012
Domain	Reg_chr_condens	MYCBP2 HERC3 HERC1	3.47e-04	22	118	3	IPR000408
Domain	-	MYCBP2 HERC3 HERC1	3.47e-04	22	118	3	2.130.10.30
Domain	DUF4704	NBEA LRBA	3.91e-04	5	118	2	IPR031570
Domain	DUF4704	NBEA LRBA	3.91e-04	5	118	2	PF15787
Domain	RCC1/BLIP-II	MYCBP2 HERC3 HERC1	3.97e-04	23	118	3	IPR009091
Domain	PH_BEACH	NBEA LRBA	5.84e-04	6	118	2	PF14844
Domain	IQ	MYO18A LRRIQ1 MYO3B INVS	1.06e-03	71	118	4	PF00612
Domain	PH-BEACH_dom	NBEA LRBA	1.08e-03	8	118	2	IPR023362
Domain	-	NBEA LRBA	1.08e-03	8	118	2	2.30.29.40
Domain	PH_BEACH	NBEA LRBA	1.08e-03	8	118	2	PS51783
Domain	BEACH_dom	NBEA LRBA	1.38e-03	9	118	2	IPR000409
Domain	BEACH	NBEA LRBA	1.38e-03	9	118	2	PS50197
Domain	Beach	NBEA LRBA	1.38e-03	9	118	2	PF02138
Domain	-	NBEA LRBA	1.38e-03	9	118	2	1.10.1540.10
Domain	Beach	NBEA LRBA	1.38e-03	9	118	2	SM01026
Domain	DNA/RNA_helicase_DEAH_CS	EP400 CHD1L DHX29	1.39e-03	35	118	3	IPR002464
Domain	IQ	MYO18A LRRIQ1 MYO3B INVS	1.73e-03	81	118	4	SM00015
Domain	DEAH_ATP_HELICASE	EP400 CHD1L DHX29	1.77e-03	38	118	3	PS00690
Domain	GDS_CDC24_CS	PLEKHG1 MCF2L DNMBP	1.90e-03	39	118	3	IPR001331
Domain	MBOAT_fam	MBOAT2 LPCAT3	2.10e-03	11	118	2	IPR004299
Domain	MBOAT	MBOAT2 LPCAT3	2.10e-03	11	118	2	PF03062
Domain	OA_transporter	SLCO5A1 SLCO1A2	2.51e-03	12	118	2	IPR004156
Domain	OATP	SLCO5A1 SLCO1A2	2.51e-03	12	118	2	PF03137
Domain	TRYPSIN_SER	PRSS38 F11 HPN KLK9	2.55e-03	90	118	4	IPR033116
Domain	IQ_motif_EF-hand-BS	MYO18A LRRIQ1 MYO3B INVS	2.55e-03	90	118	4	IPR000048
Domain	IQ	MYO18A LRRIQ1 MYO3B INVS	2.87e-03	93	118	4	PS50096
Domain	Dynein_heavy_chain_D4_dom	DNAH6 DNAH8	3.43e-03	14	118	2	IPR024317
Domain	Dynein_HC_stalk	DNAH6 DNAH8	3.43e-03	14	118	2	IPR024743
Domain	Dynein_heavy_dom-2	DNAH6 DNAH8	3.43e-03	14	118	2	IPR013602
Domain	DHC_N2	DNAH6 DNAH8	3.43e-03	14	118	2	PF08393
Domain	MT	DNAH6 DNAH8	3.43e-03	14	118	2	PF12777
Domain	AAA_8	DNAH6 DNAH8	3.43e-03	14	118	2	PF12780
Domain	ATPase_dyneun-rel_AAA	DNAH6 DNAH8	3.43e-03	14	118	2	IPR011704
Domain	AAA_5	DNAH6 DNAH8	3.43e-03	14	118	2	PF07728
Domain	DHC_fam	DNAH6 DNAH8	3.94e-03	15	118	2	IPR026983
Domain	-	ARFGEF2 ARFGEF1	3.94e-03	15	118	2	1.10.1000.11
Domain	Dynein_heavy_dom	DNAH6 DNAH8	3.94e-03	15	118	2	IPR004273
Domain	Sec7	ARFGEF2 ARFGEF1	3.94e-03	15	118	2	PF01369
Domain	Dynein_heavy	DNAH6 DNAH8	3.94e-03	15	118	2	PF03028
Domain	Sec7_alpha_orthog	ARFGEF2 ARFGEF1	3.94e-03	15	118	2	IPR023394
Domain	TRYPSIN_HIS	PRSS38 F11 HPN KLK9	4.14e-03	103	118	4	IPR018114
Domain	Sec7	ARFGEF2 ARFGEF1	4.48e-03	16	118	2	SM00222
Domain	SEC7	ARFGEF2 ARFGEF1	4.48e-03	16	118	2	PS50190
Domain	Sec7_dom	ARFGEF2 ARFGEF1	4.48e-03	16	118	2	IPR000904
Domain	TRYPSIN_SER	PRSS38 F11 HPN KLK9	4.58e-03	106	118	4	PS00135
Domain	TRYPSIN_HIS	PRSS38 F11 HPN KLK9	4.74e-03	107	118	4	PS00134
Domain	Leu-rich_rpt_typical-subtyp	LRRC66 LRRC19 LRRIQ1 TLR4 FLRT1	5.34e-03	177	118	5	IPR003591
Domain	LRR_TYP	LRRC66 LRRC19 LRRIQ1 TLR4 FLRT1	5.34e-03	177	118	5	SM00369
Domain	Peptidase_S1A	PRSS38 F11 HPN KLK9	5.75e-03	113	118	4	IPR001314
Domain	TRYPSIN_DOM	PRSS38 F11 HPN KLK9	6.11e-03	115	118	4	PS50240
Pathway	REACTOME_RAS_PROCESSING	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.21e-24	45	94	16	MM15671
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.25e-13	191	94	16	MM15289
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.20e-12	221	94	16	M27578
Pathway	REACTOME_DEUBIQUITINATION	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.61e-11	262	94	16	MM15286
Pathway	REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	5.03e-11	21	94	7	M27067
Pathway	WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION	ABL1 TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TLR4 TUBAL3	8.71e-11	55	94	9	M39613
Pathway	KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION	ABL1 TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TLR4 TUBAL3	1.03e-10	56	94	9	M2333
Pathway	REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	1.05e-10	23	94	7	M19135
Pathway	REACTOME_DEUBIQUITINATION	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.16e-10	299	94	16	M27574
Pathway	REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	2.77e-10	26	94	7	M9648
Pathway	REACTOME_MAPK_FAMILY_SIGNALING_CASCADES	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.89e-10	318	94	16	MM15278
Pathway	KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A DNAH6 DNAH8	3.46e-10	43	94	8	M47669
Pathway	REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS	TUBA3D TUBA1C TUBA3E NBEA TUBA3C TUBA1B TUBA1A TUBAL3	4.20e-10	44	94	8	M27934
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A DNAH6 DNAH8	5.08e-10	45	94	8	M47670
Pathway	REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	6.47e-10	29	94	7	M27948
Pathway	KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A	8.72e-10	17	94	6	M47768
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A	1.30e-09	18	94	6	M47753
Pathway	REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	1.37e-09	32	94	7	M29848
Pathway	REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	1.37e-09	32	94	7	M27491
Pathway	REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	1.73e-09	33	94	7	M27297
Pathway	KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A	1.89e-09	19	94	6	M47818
Pathway	KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A	1.89e-09	19	94	6	M47813
Pathway	KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A	2.69e-09	20	94	6	M47890
Pathway	KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A	2.69e-09	20	94	6	M47911
Pathway	KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A	3.74e-09	21	94	6	M47767
Pathway	REACTOME_GAP_JUNCTION_ASSEMBLY	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	4.98e-09	38	94	7	M14981
Pathway	KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A	5.12e-09	22	94	6	M47903
Pathway	KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A	6.89e-09	23	94	6	M47910
Pathway	KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A	6.89e-09	23	94	6	M47900
Pathway	KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A	9.14e-09	24	94	6	M47671
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A	9.14e-09	24	94	6	M47700
Pathway	KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A	1.20e-08	25	94	6	M47775
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A	1.20e-08	25	94	6	M47710
Pathway	REACTOME_AGGREPHAGY	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	1.46e-08	44	94	7	M29830
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A	1.55e-08	26	94	6	M47672
Pathway	REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	2.02e-08	46	94	7	M27828
Pathway	KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A	2.50e-08	28	94	6	M47898
Pathway	REACTOME_RECYCLING_PATHWAY_OF_L1	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	3.20e-08	49	94	7	M891
Pathway	REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	4.26e-08	51	94	7	M26972
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	USP17L21 USP17L4 USP17L2 GCNT3 USP17L12 USP17L1 USP17L20 USP17L11 TUBA3D MPDU1 TUBA1C TECTB TUBA3E USP17L10 USP17L19 TUBA3C USP17L18 TUBA1B USP17L17 TUBA1A ASB5 GALNT9 USP17L3 USP17L22 USP17L15 TUBAL3 MAN1B1 USP17L8 USP17L13	4.89e-08	1475	94	29	M19806
Pathway	REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	5.61e-08	53	94	7	M27651
Pathway	REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE	TUBA3D TUBA1C TUBA1B TUBA1A TUBAL3	6.88e-08	17	94	5	MM14731
Pathway	KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A	7.17e-08	33	94	6	M47901
Pathway	REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	9.42e-08	57	94	7	M27251
Pathway	KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A	1.04e-07	35	94	6	M47774
Pathway	REACTOME_KINESINS	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	1.52e-07	61	94	7	M977
Pathway	REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS	TUBA3D TUBA1C TUBA3E NBEA TUBA3C TUBA1B TUBA1A TUBAL3	2.01e-07	94	94	8	M2843
Pathway	REACTOME_PROTEIN_FOLDING	TUBA3D TUBA1C ARFGEF2 TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	2.78e-07	98	94	8	M776
Pathway	KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A	3.74e-07	43	94	6	M47773
Pathway	WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	4.39e-07	71	94	7	M39690
Pathway	REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	4.84e-07	72	94	7	M26954
Pathway	REACTOME_PKR_MEDIATED_SIGNALING	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	7.03e-07	76	94	7	M48037
Pathway	REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	7.03e-07	76	94	7	M27215
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	USP17L21 USP17L4 USP17L2 GCNT3 USP17L12 USP17L1 USP17L20 USP17L11 TUBA3D MPDU1 TUBA1C TECTB USP17L10 USP17L19 USP17L18 TUBA1B USP17L17 TUBA1A ASB5 GALNT9 USP17L3 USP17L22 USP17L15 TUBAL3 USP17L8 USP17L13	7.86e-07	1389	94	26	MM15307
Pathway	REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN	TUBA3D TUBA1C TUBA1B TUBA1A TUBAL3	8.51e-07	27	94	5	MM15549
Pathway	REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III	TUBA3D TUBA1C TUBA1B TUBA1A TUBAL3	8.51e-07	27	94	5	MM15674
Pathway	REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	9.17e-07	79	94	7	M27743
Pathway	REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS	TUBA3D TUBA1C TUBA1B TUBA1A TUBAL3	1.24e-06	29	94	5	MM15219
Pathway	REACTOME_GAP_JUNCTION_ASSEMBLY	TUBA3D TUBA1C TUBA1B TUBA1A TUBAL3	2.07e-06	32	94	5	MM14730
Pathway	REACTOME_SELECTIVE_AUTOPHAGY	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	2.23e-06	90	94	7	M29841
Pathway	KEGG_GAP_JUNCTION	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	2.23e-06	90	94	7	M4013
Pathway	REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	3.21e-06	95	94	7	M6729
Pathway	REACTOME_AGGREPHAGY	TUBA3D TUBA1C TUBA1B TUBA1A TUBAL3	3.79e-06	36	94	5	MM15669
Pathway	REACTOME_RECYCLING_PATHWAY_OF_L1	TUBA3D TUBA1C TUBA1B TUBA1A TUBAL3	4.36e-06	37	94	5	MM15102
Pathway	REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	4.52e-06	100	94	7	M27650
Pathway	REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	5.16e-06	102	94	7	M27648
Pathway	REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION	TUBA3D TUBA1C TUBA1B TUBA1A TUBAL3	1.05e-05	44	94	5	MM14606
Pathway	REACTOME_L1CAM_INTERACTIONS	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	1.59e-05	121	94	7	M872
Pathway	REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC	TUBA3D TUBA1C TUBA1B TUBA1A TUBAL3	1.62e-05	48	94	5	MM15353
Pathway	REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION	ABL1 TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	1.75e-05	170	94	8	M941
Pathway	REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	2.07e-05	126	94	7	M705
Pathway	REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	2.18e-05	127	94	7	M27181
Pathway	REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND	TUBA3D TUBA1C TUBA1B TUBA1A TUBAL3	2.40e-05	52	94	5	MM14949
Pathway	REACTOME_INTRAFLAGELLAR_TRANSPORT	TUBA3D TUBA1C TUBA3C TUBA1B TUBA1A	2.89e-05	54	94	5	M27482
Pathway	REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	3.08e-05	134	94	7	M27751
Pathway	REACTOME_HCMV_EARLY_EVENTS	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	3.73e-05	138	94	7	M29805
Pathway	REACTOME_KINESINS	TUBA3D TUBA1C TUBA1B TUBA1A TUBAL3	3.77e-05	57	94	5	MM15714
Pathway	REACTOME_RHO_GTPASES_ACTIVATE_FORMINS	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	4.09e-05	140	94	7	M27550
Pathway	REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	6.61e-05	151	94	7	M550
Pathway	REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION	TUBA3D TUBA1C TUBA3E NBEA TUBA3C TUBA1B TUBA1A TUBAL3	6.66e-05	205	94	8	M752
Pathway	WP_GPCRS_NONODORANT	HCAR2 CASR F2RL1 F2RL2 HCAR3 CXCR4 MTNR1A C3AR1 ACKR1	6.95e-05	266	94	9	MM15843
Pathway	REACTOME_PKR_MEDIATED_SIGNALING	TUBA3D TUBA1C TUBA1B TUBA1A TUBAL3	7.68e-05	66	94	5	MM17074
Pathway	REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	8.12e-05	156	94	7	M27097
Pathway	REACTOME_AUTOPHAGY	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	8.80e-05	158	94	7	M27935
Pathway	REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY	TUBA3D TUBA1C TUBA1B TUBA1A TUBAL3	8.86e-05	68	94	5	MM14921
Pathway	REACTOME_L1CAM_INTERACTIONS	TUBA3D TUBA1C TUBA1B TUBA1A TUBAL3	8.86e-05	68	94	5	MM14968
Pathway	REACTOME_HCMV_INFECTION	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	1.03e-04	162	94	7	M29804
Pathway	REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT	TUBA3D TUBA1C TUBA1B TUBA1A TUBAL3	1.24e-04	73	94	5	MM15491
Pathway	REACTOME_SELECTIVE_AUTOPHAGY	TUBA3D TUBA1C TUBA1B TUBA1A TUBAL3	1.24e-04	73	94	5	MM15672
Pathway	REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION	TUBA3D MPDU1 TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3 MAN1B1	2.06e-04	307	94	9	M894
Pathway	WP_GPCRS_CLASS_A_RHODOPSINLIKE	HCAR2 F2RL1 F2RL2 HCAR3 CXCR4 MTNR1A C3AR1	2.42e-04	186	94	7	MM15994
Pathway	REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	2.50e-04	187	94	7	M961
Pathway	BIOCARTA_LIS1_PATHWAY	ABL1 DNAH6 DNAH8	2.57e-04	19	94	3	M22005
Pathway	REACTOME_SEPARATION_OF_SISTER_CHROMATIDS	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	2.85e-04	191	94	7	M29614
Pathway	BIOCARTA_MTA3_PATHWAY	TUBA1C TUBA1B TUBA1A	3.01e-04	20	94	3	MM1383
Pathway	REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES	TUBA3D TUBA1C TUBA1B TUBA1A TUBAL3	3.33e-04	90	94	5	MM14979
Pathway	REACTOME_MITOTIC_G2_G2_M_PHASES	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	3.76e-04	200	94	7	M864
Pathway	REACTOME_CILIUM_ASSEMBLY	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	3.88e-04	201	94	7	M27472
Pathway	REACTOME_INTRAFLAGELLAR_TRANSPORT	TUBA3D TUBA1C TUBA1B TUBA1A	3.93e-04	52	94	4	MM15211
Pathway	REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES	TUBA3D TUBA1C TUBA1B TUBA1A TUBAL3	4.07e-04	94	94	5	MM14515
Pubmed	DUB-1, a deubiquitinating enzyme with growth-suppressing activity.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.78e-36	21	122	16	8622927
Pubmed	DUB-1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.78e-36	21	122	16	14583620
Pubmed	DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.78e-36	21	122	16	11468161
Pubmed	The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.78e-36	21	122	16	8756639
Pubmed	Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.78e-36	21	122	16	12447969
Pubmed	DUB-1, a fate determinant of dynein heavy chain in B-lymphocytes, is regulated by the ubiquitin-proteasome pathway.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.78e-36	21	122	16	18980247
Pubmed	JAK2 is required for induction of the murine DUB-1 gene.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.38e-35	22	122	16	9154835
Pubmed	DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.36e-34	24	122	16	8995226
Pubmed	Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.76e-34	25	122	16	21115691
Pubmed	Decabromodiphenyl ethane affects embryonic development by interfering with nuclear F-actin in zygotes and leads to cognitive and social disorders in offspring mice.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	9.74e-34	26	122	16	35816173
Pubmed	Minor Splicing Factors Zrsr1 and Zrsr2 Are Essential for Early Embryo Development and 2-Cell-Like Conversion.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.23e-32	29	122	16	32527007
Pubmed	Cdc25A and Dub3 in a high-stakes balancing act.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.10e-31	33	122	16	20228807
Pubmed	The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin cluster.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.95e-31	34	122	16	20403174
Pubmed	DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.95e-31	34	122	16	14699124
Pubmed	The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.95e-31	34	122	16	15780755
Pubmed	USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.95e-31	34	122	16	19188362
Pubmed	Unstable transmission of the RS447 human megasatellite tandem repetitive sequence that contains the USP17 deubiquitinating enzyme gene.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.95e-31	34	122	16	11941478
Pubmed	Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.95e-31	34	122	16	17109758
Pubmed	The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.95e-31	34	122	16	20388806
Pubmed	Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.95e-31	34	122	16	20715989
Pubmed	Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.95e-31	34	122	16	9806828
Pubmed	The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.95e-31	34	122	16	20368735
Pubmed	The RS447 human megasatellite tandem repetitive sequence encodes a novel deubiquitinating enzyme with a functional promoter.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.95e-31	34	122	16	10936051
Pubmed	The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.95e-31	34	122	16	21448158
Pubmed	Cytokine-regulated protein degradation by the ubiquitination system.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	7.25e-31	35	122	16	16611142
Pubmed	Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	7.25e-31	35	122	16	21239494
Pubmed	The deubiquitinating enzyme USP17 blocks N-Ras membrane trafficking and activation but leaves K-Ras unaffected.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.30e-30	36	122	16	20147298
Pubmed	Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.29e-30	37	122	16	20228808
Pubmed	DUX is a non-essential synchronizer of zygotic genome activation.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	8.42e-28	50	122	16	31806660
Pubmed	Huwe1, a novel cellular interactor of Gag-Pol through integrase binding, negatively influences HIV-1 infectivity.	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A	1.37e-13	9	122	6	21167302
Pubmed	High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency.	USP17L4 USP17L2 USP17L1 USP17L3 USP17L15 USP17L8	3.42e-13	10	122	6	24207026
Pubmed	Cell cycle-dependent expression of Dub3, Nanog and the p160 family of nuclear receptor coactivators (NCoAs) in mouse embryonic stem cells.	USP17L4 USP17L2 USP17L1 USP17L3 USP17L15 USP17L8	1.49e-12	12	122	6	24695638
Pubmed	ES cell neural differentiation reveals a substantial number of novel ESTs.	USP17L4 USP17L2 USP17L1 USP17L3 USP17L15 USP17L8	4.83e-12	14	122	6	11793228
Pubmed	USP7 represses lineage differentiation genes in mouse embryonic stem cells by both catalytic and noncatalytic activities.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 TUBA3D USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 NNT USP17L15 USP17L8 USP17L13	2.73e-11	674	122	18	37196079
Pubmed	CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1.	USP17L4 USP17L2 USP17L1 USP17L3 USP17L15 USP17L8	4.30e-11	19	122	6	28067227
Pubmed	HIV-1 Tat, apoptosis and the mitochondria: a tubulin link?	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A	4.30e-11	19	122	6	15698476
Pubmed	HIV-1 Tat protein enhances microtubule polymerization.	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A	4.30e-11	19	122	6	15691386
Pubmed	F-Box Protein FBXO22 Mediates Polyubiquitination and Degradation of CD147 to Reverse Cisplatin Resistance of Tumor Cells.	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A	1.17e-10	22	122	6	28117675
Pubmed	Six mouse alpha-tubulin mRNAs encode five distinct isotypes: testis-specific expression of two sister genes.	TUBA3D TUBA1C TUBA1B TUBA1A	2.15e-09	6	122	4	3785200
Pubmed	Mutation analysis of 12 candidate genes for distal hereditary motor neuropathy type II (distal HMN II) linked to 12q24.3.	TUBA1C TUBA1B HCAR3 TUBA1A	2.15e-09	6	122	4	12090300
Pubmed	Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection.	TUBA1C TUBA3C TUBA1B TUBA1A	9.98e-09	8	122	4	16148047
Pubmed	Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity.	TUBA3D TUBA3E TUBA3C TUBA1B TUBA1A	1.23e-08	22	122	5	23826228
Pubmed	Human and mouse proteases: a comparative genomic approach.	USP17L4 USP17L2 USP17L1 PRSS38 USP17L3 USP17L15 USP17L8	1.54e-08	81	122	7	12838346
Pubmed	The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis.	TUBA1C TUBA3C TUBA1B TUBA1A	6.98e-08	12	122	4	15331610
Pubmed	HIV-1 rev depolymerizes microtubules to form stable bilayered rings.	TUBA1C TUBA3C TUBA1B TUBA1A	1.01e-07	13	122	4	10908577
Pubmed	HIV-1 Tat targets microtubules to induce apoptosis, a process promoted by the pro-apoptotic Bcl-2 relative Bim.	TUBA1C TUBA3C TUBA1B TUBA1A	1.40e-07	14	122	4	12486001
Pubmed	Embryonic demise caused by targeted disruption of a cysteine protease Dub-2.	USP17L2 USP17L15 USP17L13	1.68e-07	4	122	3	22984479
Pubmed	Susceptibility to virus-cell fusion at the plasma membrane is reduced through expression of HIV gp41 cytoplasmic domains.	TUBA1C TUBA3C TUBA1A	1.68e-07	4	122	3	18400243
Pubmed	A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L19 USP17L18 USP17L17	2.22e-07	119	122	7	28625976
Pubmed	Requirement for an intact T-cell actin and tubulin cytoskeleton for efficient assembly and spread of human immunodeficiency virus type 1.	TUBA1C TUBA3C TUBA1B TUBA1A	3.31e-07	17	122	4	17360745
Pubmed	The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro.	TUBA3C TUBA1B TUBA1A	8.36e-07	6	122	3	7651436
Pubmed	Inhibitory effect of HIV-1 Tat protein on the sodium-D-glucose symporter of human intestinal epithelial cells.	TUBA1C TUBA3C TUBA1A	8.36e-07	6	122	3	16327313
Pubmed	HIV-1-mediated apoptosis of neuronal cells: Proximal molecular mechanisms of HIV-1-induced encephalopathy.	TUBA1C TUBA3C TUBA1B TUBA1A	1.00e-06	22	122	4	15103018
Pubmed	Codon modification of Tuba1a alters mRNA levels and causes a severe neurodevelopmental phenotype in mice.	TUBA1C TUBA1B TUBA1A	1.46e-06	7	122	3	36681692
Pubmed	SIAH-1 interacts with alpha-tubulin and degrades the kinesin Kid by the proteasome pathway during mitosis.	TUBA3C TUBA1B TUBA1A	1.46e-06	7	122	3	11146551
Pubmed	Interaction between metabotropic glutamate receptor 7 and alpha tubulin.	TUBA3C TUBA1B TUBA1A	3.48e-06	9	122	3	11953448
Pubmed	Inhibition of microtubule assembly in osteoblasts stimulates bone morphogenetic protein 2 expression and bone formation through transcription factor Gli2.	TUBA1C TUBA1B TUBA1A	3.48e-06	9	122	3	19103752
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	MYCBP2 UBR4 PKD1L1 MMP23B CHD1L CYP46A1 TUBA1B HERC3 DNAH6	5.51e-06	361	122	9	26167880
Pubmed	CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer.	TUBA1C TUBA3E TUBA3C GSN TUBA1B TUBA1A MYO3B TUBAL3	8.54e-06	288	122	8	31501420
Pubmed	Activated niacin receptor HCA2 inhibits chemoattractant-mediated macrophage migration via Gβγ/PKC/ERK1/2 pathway and heterologous receptor desensitization.	HCAR2 HCAR3	1.22e-05	2	122	2	28186140
Pubmed	The Immunometabolomic Interface Receptor Hydroxycarboxylic Acid Receptor 2 Mediates the Therapeutic Effects of Dimethyl Fumarate in Autoantibody-Induced Skin Inflammation.	HCAR2 HCAR3	1.22e-05	2	122	2	30154797
Pubmed	The superfamily of organic anion transporting polypeptides.	SLCO5A1 SLCO1A2	1.22e-05	2	122	2	12507753
Pubmed	The role of HCA2 (GPR109A) in regulating macrophage function.	HCAR2 HCAR3	1.22e-05	2	122	2	23882124
Pubmed	Crosstalk between microbiome, regulatory T cells and HCA2 orchestrates the inflammatory response in a murine psoriasis model.	HCAR2 HCAR3	1.22e-05	2	122	2	36891315
Pubmed	Parabacteroides distasonis ameliorates insulin resistance via activation of intestinal GPR109a.	HCAR2 HCAR3	1.22e-05	2	122	2	38007572
Pubmed	Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE.	HCAR2 HCAR3	1.22e-05	2	122	2	24691444
Pubmed	Butyrate ameliorates caerulein-induced acute pancreatitis and associated intestinal injury by tissue-specific mechanisms.	HCAR2 HCAR3	1.22e-05	2	122	2	31347703
Pubmed	Loss of GPR109A/HCAR2 induces aging-associated hepatic steatosis.	HCAR2 HCAR3	1.22e-05	2	122	2	30659164
Pubmed	Expression and localization of GPR109A (PUMA-G/HM74A) mRNA and protein in mammalian retinal pigment epithelium.	HCAR2 HCAR3	1.22e-05	2	122	2	19223991
Pubmed	Niacin increases adiponectin and decreases adipose tissue inflammation in high fat diet-fed mice.	HCAR2 HCAR3	1.22e-05	2	122	2	23967184
Pubmed	The Giant HECT E3 Ubiquitin Ligase HERC1 Is Aberrantly Expressed in Myeloid Related Disorders and It Is a Novel BCR-ABL1 Binding Partner.	ABL1 HERC1	1.22e-05	2	122	2	33477751
Pubmed	Involvement of the Niacin Receptor GPR109a in the LocalControl of Glucose Uptake in Small Intestine of Type 2Diabetic Mice.	HCAR2 HCAR3	1.22e-05	2	122	2	26371038
Pubmed	Alloreactive T cells deficient of the short-chain fatty acid receptor GPR109A induce less graft-versus-host disease.	HCAR2 HCAR3	1.22e-05	2	122	2	34653248
Pubmed	Phenolic acids suppress adipocyte lipolysis via activation of the nicotinic acid receptor GPR109A (HM74a/PUMA-G).	HCAR2 HCAR3	1.22e-05	2	122	2	19136666
Pubmed	G Protein-Coupled Receptor 109A Maintains the Intestinal Integrity and Protects Against ETEC Mucosal Infection by Promoting IgA Secretion.	HCAR2 HCAR3	1.22e-05	2	122	2	33488584
Pubmed	Lactate-induced activation of HCA2 improves survival in mice with sepsis.	HCAR2 HCAR3	1.22e-05	2	122	2	30951370
Pubmed	Reduced fibrinolytic resistance in patients with factor XI deficiency. Evidence of a thrombin-independent impairment of the thrombin-activatable fibrinolysis inhibitor pathway.	CPB2 F11	1.22e-05	2	122	2	27094709
Pubmed	Arf guanine nucleotide-exchange factors BIG1 and BIG2 regulate nonmuscle myosin IIA activity by anchoring myosin phosphatase complex.	ARFGEF2 ARFGEF1	1.22e-05	2	122	2	23918382
Pubmed	Niacin Ameliorates Hepatic Steatosis by Inhibiting De Novo Lipogenesis Via a GPR109A-Mediated PKC-ERK1/2-AMPK Signaling Pathway in C57BL/6 Mice Fed a High-Fat Diet.	HCAR2 HCAR3	1.22e-05	2	122	2	31858105
Pubmed	Exploring the role of the metabolite-sensing receptor GPR109a in diabetic nephropathy.	HCAR2 HCAR3	1.22e-05	2	122	2	32068460
Pubmed	The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome.	HCAR2 HCAR3	1.22e-05	2	122	2	30657794
Pubmed	Melatonin alleviates titanium nanoparticles induced osteolysis via activation of butyrate/GPR109A signaling pathway.	HCAR2 HCAR3	1.22e-05	2	122	2	34092246
Pubmed	Regulation of brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1) and BIG2 activity via PKA and protein phosphatase 1gamma.	ARFGEF2 ARFGEF1	1.22e-05	2	122	2	17360629
Pubmed	Identification and localization of two brefeldin A-inhibited guanine nucleotide-exchange proteins for ADP-ribosylation factors in a macromolecular complex.	ARFGEF2 ARFGEF1	1.22e-05	2	122	2	10716990
Pubmed	Molecular identification of high and low affinity receptors for nicotinic acid.	HCAR2 HCAR3	1.22e-05	2	122	2	12522134
Pubmed	The role of thrombin activatable fibrinolysis inhibitor and factor XI in platelet-mediated fibrinolysis resistance: a thromboelastographic study in whole blood.	CPB2 F11	1.22e-05	2	122	2	20961395
Pubmed	G Protein-Coupled Receptor 109A and Host Microbiota Modulate Intestinal Epithelial Integrity During Sepsis.	HCAR2 HCAR3	1.22e-05	2	122	2	30271409
Pubmed	Membrane association of the Arabidopsis ARF exchange factor GNOM involves interaction of conserved domains.	ARFGEF2 ARFGEF1	1.22e-05	2	122	2	18203920
Pubmed	Niacin fine-tunes energy homeostasis through canonical GPR109A signaling.	HCAR2 HCAR3	1.22e-05	2	122	2	30596513
Pubmed	The niacin receptor HCAR2 modulates microglial response and limits disease progression in a mouse model of Alzheimer's disease.	HCAR2 HCAR3	1.22e-05	2	122	2	35320002
Pubmed	GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing.	HCAR2 HCAR3	1.22e-05	2	122	2	16322797
Pubmed	Nicotinic acid receptor agonists.	HCAR2 HCAR3	1.22e-05	2	122	2	18983141
Pubmed	Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic- and GPR109a-mediated mechanisms.	HCAR2 HCAR3	1.22e-05	2	122	2	31366236
Pubmed	Modulation of the stability and activities of HIV-1 Tat by its ubiquitination and carboxyl-terminal region.	TUBA1B TUBA1A	1.22e-05	2	122	2	25328666
Pubmed	Analysis of proteinase-activated receptor 2 and TLR4 signal transduction: a novel paradigm for receptor cooperativity.	F2RL1 TLR4	1.22e-05	2	122	2	18622013
Pubmed	GPR109A gene deletion ameliorates gonadectomy-induced bone loss in mice.	HCAR2 HCAR3	1.22e-05	2	122	2	35489706
Pubmed	Redundant roles of BIG2 and BIG1, guanine-nucleotide exchange factors for ADP-ribosylation factors in membrane traffic between the trans-Golgi network and endosomes.	ARFGEF2 ARFGEF1	1.22e-05	2	122	2	18417613
Pubmed	Deorphanization of GPR109B as a receptor for the beta-oxidation intermediate 3-OH-octanoic acid and its role in the regulation of lipolysis.	HCAR2 HCAR3	1.22e-05	2	122	2	19561068
Pubmed	The niacin/butyrate receptor GPR109A suppresses mammary tumorigenesis by inhibiting cell survival.	HCAR2 HCAR3	1.22e-05	2	122	2	24371223
Pubmed	High dietary niacin may increase prostaglandin formation but does not increase tumor formation in ApcMin/+ mice.	HCAR2 HCAR3	1.22e-05	2	122	2	21774590
Interaction	TCP11L2 interactions	TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	1.30e-09	21	112	6	int:TCP11L2
Interaction	ORAI1 interactions	ARFGEF2 ARFGEF1 FANCD2 TUBA1B CXCR4	5.54e-06	46	112	5	int:ORAI1
Interaction	VAV1 interactions	ABL1 TUBA3E SLA TUBA3C FANCD2 TUBA1B TUBA1A CXCR4	4.11e-05	228	112	8	int:VAV1
Interaction	KLK11 interactions	TUBA1C CHD1L TUBA1A KLK9	4.64e-05	36	112	4	int:KLK11
Interaction	GZMH interactions	TUBA1C ARFGEF2 ARFGEF1 FANCD2 TUBA1A	5.75e-05	74	112	5	int:GZMH
Interaction	CD79B interactions	TUBA1C ARFGEF2 FANCD2 TUBA1A CXCR4 MAN1B1	6.17e-05	122	112	6	int:CD79B
Interaction	INSYN2A interactions	TUBA1C CHD1L TUBA1A LRBA	6.40e-05	39	112	4	int:INSYN2A
Interaction	FLT3 interactions	USP17L21 USP17L12 USP17L20 USP17L11 UBR4 USP17L19 SLA USP17L18 USP17L17	7.17e-05	318	112	9	int:FLT3
Interaction	CAPSL interactions	TUBA1C TUBA1B TUBA1A	7.24e-05	15	112	3	int:CAPSL
Interaction	STAT2 interactions	EP400 MYCBP2 UBR4 FANCD2 CXCR4	8.87e-05	81	112	5	int:STAT2
Interaction	BACE2 interactions	ABL1 TUBA1C TUBA3C TUBA1B HPN	9.41e-05	82	112	5	int:BACE2
Cytoband	4p16.1	USP17L21 USP17L23 USP17L12 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	3.14e-18	79	122	12	4p16.1
Cytoband	Ensembl 112 genes in cytogenetic band chr4p16	USP17L21 USP17L23 USP17L12 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	9.86e-13	222	122	12	chr4p16
Cytoband	8p23.1	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	6.01e-05	154	122	5	8p23.1
Cytoband	12q13.12	TUBA1C TUBA1B TUBA1A	1.44e-04	38	122	3	12q13.12
Cytoband	Ensembl 112 genes in cytogenetic band chr8p23	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	4.21e-04	234	122	5	chr8p23
Cytoband	Ensembl 112 genes in cytogenetic band chr8q13	XKR9 ARFGEF1 SLCO5A1	1.12e-03	76	122	3	chr8q13
Cytoband	8q13.3	XKR9 SLCO5A1	1.16e-03	19	122	2	8q13.3
Cytoband	5q13	F2RL1 F2RL2	1.56e-03	22	122	2	5q13
GeneFamily	Tubulins	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A TUBAL3	7.29e-12	26	72	7	778
GeneFamily	Hydroxy-carboxylic acid receptors	HCAR2 HCAR3	4.68e-05	3	72	2	200
GeneFamily	F2R receptors	F2RL1 F2RL2	9.34e-05	4	72	2	219
GeneFamily	Membrane bound O-acyltransferases	MBOAT2 LPCAT3	3.24e-04	7	72	2	1036
GeneFamily	WD repeat domain containing\|BEACH domain containing	NBEA LRBA	5.53e-04	9	72	2	1230
GeneFamily	Dyneins, axonemal	DNAH6 DNAH8	2.05e-03	17	72	2	536
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	PLEKHG1 MCF2L DNMBP	2.32e-03	66	72	3	722
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	ARFGEF2 NBEA	5.92e-03	29	72	2	396
GeneFamily	Kelch like\|BTB domain containing	KLHL1 KLHL32	1.21e-02	42	72	2	617
Coexpression	MADAN_DPPA4_TARGETS	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 PLEKHG1 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.61e-23	86	120	17	MM1312
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 KLK9 USP17L22 USP17L15 USP17L8 USP17L13	1.97e-21	112	120	17	MM1095
Coexpression	GERY_CEBP_TARGETS	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.11e-17	160	120	16	MM1155
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 GSN USP17L18 ANGPTL2 USP17L17 CXCR4 HPN USP17L3 USP17L22 USP17L15 HYAL2 USP17L8 USP17L13	1.81e-12	647	120	21	MM981
Coexpression	BRUINS_UVC_RESPONSE_LATE	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 MMP23B USP17L10 USP17L19 USP17L18 USP17L17 TUBA1A TLR4 USP17L3 ROBO3 USP17L22 DNMBP MTCH1 USP17L15 HYAL2 USP17L8 USP17L13	4.72e-09	1198	120	23	MM1062
Coexpression	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 GSN EPM2AIP1 USP17L18 ANGPTL2 USP17L17 CXCR4 HPN USP17L3 HERC1 USP17L22 USP17L15 HYAL2 USP17L8 USP17L13	7.28e-09	1226	120	23	MM979
Coexpression	MARSON_BOUND_BY_FOXP3_STIMULATED	USP17L21 USP17L4 USP17L2 GCNT3 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 CHD1L USP17L19 F2RL2 EPM2AIP1 USP17L18 USP17L17 USP17L3 HERC1 USP17L22 USP17L15 USP17L8 USP17L13	1.72e-08	1072	120	21	MM1031
Coexpression	GSE1925_3H_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN	ABL1 DHRS1 GSN TUBA1B LRBA CDKN2AIPNL MTCH1	3.90e-05	200	120	7	M6301
Coexpression	GSE22432_CDC_VS_COMMON_DC_PROGENITOR_UP	ZMYND8 MYO18A ARFGEF2 F2RL1 MGST2 TNK2 DNAH8	3.90e-05	200	120	7	M7831
Coexpression	GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_UP	ABL1 GALK2 MYCBP2 ARFGEF2 GSN GALNT9 NNT	3.90e-05	200	120	7	M8644
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma\|TCGA-Brain / Sample_Type by Project: Shred V9	MYO18A KLHL32 MBOAT2 SLCO1A2 FLRT1 HERC1	6.72e-06	177	115	6	e8ab340b20cd41554c3841fe980e078e878af35f
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ZMYND8 CASR PGAP6 F11 MYO3B LRBA	8.13e-06	183	115	6	31ab55d5f3639f5964541d5eae23044dbda3356e
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ZMYND8 CASR PGAP6 F11 MYO3B LRBA	8.65e-06	185	115	6	898a093757f86be3e18d2ef1f16a71f50ef81dc3
ToppCell	PBMC-Control-cDC_7\|Control / Compartment, Disease Groups and Clusters	TUBA1C GSN TUBA1B TUBA1A CXCR4 ROBO3	1.17e-05	195	115	6	c8f9f2911c2f963b5d1336fbb5567bfc7f3e737b
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-D\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MYO18A HAPLN2 KLHL32 ABCA8 GSN HPN	1.24e-05	197	115	6	54fb207638e211f8efdb13003ae62a6b1f003b09
ToppCell	NS-critical-d_07-13-Myeloid-Neutrophil\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	HCAR2 SLA HCAR3 CXCR4 TLR4 C3AR1	1.24e-05	197	115	6	f38037dfa6c33e9336130d0cc65eaba0f120efb9
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	KLHL1 ZNF462 CNTNAP5 TM7SF2 TNK2 FLRT1	1.35e-05	200	115	6	ad777683adeb2ce45ade570386235e311fa7ea2d
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARFGEF2 PGAP6 MGST2 CXCR4 DHX29	2.48e-05	133	115	5	f6e9a1301a3379847b215303a9b0c028841e2cc0
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARFGEF2 PGAP6 MGST2 CXCR4 DHX29	2.48e-05	133	115	5	292ecfcadbaf15e0d34a3ab9bf511ab1065888bd
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	LRRC19 SLCO1A2 DNAH8 NNT INVS	5.30e-05	156	115	5	a5930b455e5c8586c43c50106ab4d8a1e5e9e3d6
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GCNT3 F11 GALNT9 HERC3 ROBO3	5.47e-05	157	115	5	1e3a4a7193d95f09d71c2dfe704b8e626c6d9624
ToppCell	PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GALK2 MYCBP2 CUBN MYO3B TLR4	6.34e-05	162	115	5	d712bc31840ad1523e3dbf884acbb428a8995001
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CHD1L LIM2 LRRC19 SLCO1A2 ROBO3	6.72e-05	164	115	5	4ef776d1bab4103d42d3a4f22cdfb49e8d2bc5a0
ToppCell	TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-7\|TCGA-Thryoid / Sample_Type by Project: Shred V9	CYP46A1 MMEL1 FLRT1 DHX29 MTCH1	7.33e-05	167	115	5	01c42e555913b17e62846325cc17b3d8f92da1e1
ToppCell	droplet-Lung-LUNG-1m-Lymphocytic-regulatory_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRRC66 F2RL1 SLA MGST2 TUBAL3	8.42e-05	172	115	5	ce444463f69bbb05c933615a0f1f43ddde3eee1c
ToppCell	droplet-Lung-LUNG-1m-Lymphocytic-Regulatory_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRRC66 F2RL1 SLA MGST2 TUBAL3	8.42e-05	172	115	5	2c993a93ac91dcf6061eec001f51f8cccb6ee264
ToppCell	Control-Endothelial_cells-Systemic_venous_endothelial_cells\|Control / group, cell type (main and fine annotations)	OR5AK2 PKD1L1 PLEKHG1 MCF2L ACKR1	8.42e-05	172	115	5	c55dce1ed3ed7312394b4e050e1de852a994e130
ToppCell	Multiple_Sclerosis-Lymphocyte-T_NK-ILC\|Multiple_Sclerosis / Disease, Lineage and Cell Type	PRSS38 TUBA3D MBOAT2 LRRIQ1 MAN1B1	8.89e-05	174	115	5	7c50bf9da37711266cc077eef4e54b58463f1d37
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KLHL1 ZNF462 CFAP54 LRRIQ1 SLCO1A2	9.13e-05	175	115	5	284fdc7a9d303636a637041846850d19d114861a
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZMYND8 CASR F11 MYO3B LRBA	1.04e-04	180	115	5	9e09b3dfe344b5d50520711513d389865d73a861
ToppCell	droplet-Marrow-BM-1m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BCAT1 KLHL32 GALNT9 NNT MTCH1	1.07e-04	181	115	5	89c551de26de047c316c91ac1d97bdf728a33d9e
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ZMYND8 CASR PGAP6 F11 MYO3B	1.10e-04	182	115	5	041bc819e6cf2618bf86bce8dfe2df673f392ba3
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HAPLN2 ABCA8 GSN HPN SLCO1A2	1.13e-04	183	115	5	93213124e55d1b673dd345188caf8b5bd31d99fe
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HAPLN2 ABCA8 GSN HPN SLCO1A2	1.16e-04	184	115	5	f6d6b3ddada66dae28d3306415bf4efe0934208a
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-D\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SLA GSN TUBA1B MGST2 C3AR1	1.16e-04	184	115	5	97ae5ffecf90df42cc8eea2a247ca589f35a4783
ToppCell	droplet-Marrow-BM-1m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BCAT1 KLHL32 GALNT9 NNT MTCH1	1.16e-04	184	115	5	69348c9237e44f7752ac01f60e733ad41580fdb8
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRRC66 F2RL1 MBOAT2 PLEKHG1 NNT	1.19e-04	185	115	5	af86e75096c1812ae27a78405355957ee8043d84
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CASR F11 HPN MYO3B LRBA	1.19e-04	185	115	5	03f64a7132b13a01ba47187e0e15c13ac88f7cb2
ToppCell	343B-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	F2RL1 GSN TUBA1B TUBA1A C3AR1	1.22e-04	186	115	5	9673367cb53bafb873a01ef6bda11d9f392ce648
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF462 CFAP54 LRRIQ1 SLCO1A2 DNAH6	1.22e-04	186	115	5	5c4ffe4e4d5536ae9f8794277fe032c693e7dd56
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CASR F11 HPN MYO3B LRBA	1.22e-04	186	115	5	1850583d23903d08226aeb0edb3e07b0994330e4
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CASR F11 HPN MYO3B LRBA	1.22e-04	186	115	5	4dafc215c42e7949f932a3627359c107943b5d6b
ToppCell	Adult-Epithelial-club_cell-D231\|Adult / Lineage, Cell type, age group and donor	CASR NBEA CUBN PLEKHG1 SLC39A6	1.25e-04	187	115	5	ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86
ToppCell	COVID_non-vent-Myeloid-Dendritic\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	TUBA1C BCAT1 GSN TUBA1B TUBA1A	1.25e-04	187	115	5	936aaca144b79a809617cbe3058bf434a4b3d46a
ToppCell	human_hepatoblastoma-Tumor_cells-T2\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	CPB2 PLEKHG1 MGST2 HPN LRBA	1.25e-04	187	115	5	f3e37c18ac6471c7992609bbddfa4975571c815c
ToppCell	COVID_non-vent-Myeloid-Dendritic-cDC\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	TUBA1C BCAT1 GSN TUBA1B TUBA1A	1.25e-04	187	115	5	55fe4e8b4f301876716c1af15c34d42164f2358e
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_0\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GSN SLCO5A1 MGST2 TUBA1A ROBO3	1.28e-04	188	115	5	9fc3819aae5a2b2534cb131d467435b5cfc420d6
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRRC66 CASR F2RL1 MBOAT2 NNT	1.28e-04	188	115	5	14e120b20e76baa07b6510a94f0c2dcdfdd52357
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_0\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	GSN SLCO5A1 MGST2 TUBA1A ROBO3	1.28e-04	188	115	5	5e5d779ea079d3b2a1ef650b06b9f5cc1ffef5e7
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRRC66 CASR F2RL1 MBOAT2 NNT	1.31e-04	189	115	5	443359d90fafae0c1de6bdcce9e8c95df6ea4de8
ToppCell	droplet-Kidney-nan-21m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRRC66 CASR F2RL1 LRBA ROBO3	1.34e-04	190	115	5	c247562df3e1aa3173c9f01a74d5831f0764a1b2
ToppCell	droplet-Kidney-nan-21m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRRC66 CASR F2RL1 LRBA ROBO3	1.34e-04	190	115	5	5cea8298c8336c136ba009630c9e48d4bc832cb2
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HAPLN2 ABCA8 GSN SLCO1A2 TLR4	1.38e-04	191	115	5	2b056cbe2e82e056e1f798974999378460eb1d16
ToppCell	5'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BCAT1 PLEKHG1 MCF2L ACKR1 HYAL2	1.41e-04	192	115	5	eafead22bba48ac5ee568faa8946c444445c1034
ToppCell	NS-moderate-d_16-33-Myeloid-Neutrophil\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	HCAR2 SLA HCAR3 CXCR4 TLR4	1.41e-04	192	115	5	545c3990cbe3c04bfd95a0ab7499d2c4af509be1
ToppCell	NS-critical-d_0-4-Myeloid-Neutrophil\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	HCAR2 SLA HCAR3 CXCR4 C3AR1	1.41e-04	192	115	5	3db74359c30172a51177e00eac1f48f483e15578
ToppCell	moderate-Myeloid-Neutrophil\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	HCAR2 SLA HCAR3 CXCR4 TLR4	1.41e-04	192	115	5	8105408400dac5dcb0ce62b558433257559c9f09
ToppCell	COVID-19-kidney-Myeloid\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HCAR2 SLA HCAR3 CXCR4 C3AR1	1.41e-04	192	115	5	0b9d22a222f1201e375f8e55cace9ef939febae4
ToppCell	human_hepatoblastoma-Tumor_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	ARFGEF2 CPB2 MGST2 HPN SLCO1A2	1.44e-04	193	115	5	503a979328c68b096680b71359a26f02fafdff35
ToppCell	facs-Brain_Myeloid-Cortex-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLA GSN TUBA1B TUBA1A LPCAT3	1.48e-04	194	115	5	2224c7c943cfd5c1a329dfcf19d6e5ef8c49d85d
ToppCell	ILEUM-inflamed-(3)_mature_DC\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	TUBA1C MBOAT2 GSN SLCO5A1 CXCR4	1.48e-04	194	115	5	369bbf4e8e2d674e5a51a614b52b97d05d3ab9c7
ToppCell	IPF-Multiplet-Multiplet\|IPF / Disease state, Lineage and Cell class	NBEA KLHL32 CFAP54 LRRIQ1 DNAH6	1.52e-04	195	115	5	fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCell	IIH-mono3-\|IIH / Condition, Cell_class and T cell subcluster	BCAT1 GSN MGST2 C3AR1 MCF2L	1.52e-04	195	115	5	28a858b04a7b413916c07a8d880f5ea02e985461
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NBEA CFAP54 LRRIQ1 TUBA1A DNAH6	1.52e-04	195	115	5	649fd2336e963f6a150d182a53ad5dd838ca80b1
ToppCell	droplet-Liver-LIVER-NPC-1m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLEKHG1 TUBA1A FLRT1 ACKR1 HYAL2	1.52e-04	195	115	5	126f46dd15dddcf5701144718bb8ba1ce84b2d1d
ToppCell	CF-Myeloid\|CF / Disease state, Lineage and Cell class	HCAR2 SLA HCAR3 CXCR4 C3AR1	1.52e-04	195	115	5	ecf604de496f389a49429d0bb211e1db6019cc8b
ToppCell	IPF-Multiplet\|IPF / Disease state, Lineage and Cell class	NBEA KLHL32 CFAP54 LRRIQ1 DNAH6	1.52e-04	195	115	5	eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 ARFGEF1 NBEA KLHL32 HERC1	1.52e-04	195	115	5	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NBEA CFAP54 LRRIQ1 TUBA1A DNAH6	1.52e-04	195	115	5	129ad5f4253ecb1a8477cc38773e6e91ea9570b0
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NBEA CFAP54 LRRIQ1 TUBA1A DNAH6	1.52e-04	195	115	5	3e70ee987d66d450062d5df3d7c733ccc7344470
ToppCell	IIH-mono3\|IIH / Condition, Cell_class and T cell subcluster	BCAT1 GSN MGST2 C3AR1 MCF2L	1.52e-04	195	115	5	c6dd5af582d257be64b718e30f60220c1bf1738a
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 ARFGEF1 NBEA KLHL32 HERC1	1.52e-04	195	115	5	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ZNF462 TUBA1B ANGPTL2 TUBA1A TNK2	1.55e-04	196	115	5	8faac7fbdee3a9297023c3151ef1751605413e44
ToppCell	nucseq-Endothelial-Endothelial_Vascular\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MBOAT2 PLEKHG1 MCF2L ACKR1 HYAL2	1.55e-04	196	115	5	686533fd3fba8e4df96b9dd1307e870e89db4332
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-C\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HAPLN2 KLHL32 ABCA8 GSN SLCO1A2	1.55e-04	196	115	5	77feb22fd0b0b1df03375da472134412e9e69c90
ToppCell	wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-airway_progenitor_early\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	PLEKHG1 LRRIQ1 HPN TM7SF2 LRBA	1.59e-04	197	115	5	4ae08ccb6f1da626c4f0fb0140a2811cb6e31ba1
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids\|saliva / Compartment, severity and other cell annotations on 10x 3' data (130k)	COLGALT1 TUBA1A CXCR4 PCNX1 C3AR1	1.59e-04	197	115	5	c747d05bb032abf8dad46ff6f4d1951bbe64b3b4
ToppCell	10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-neutrophil\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	HCAR2 SLA GSN HCAR3 C3AR1	1.63e-04	198	115	5	82f6ac18c3a6487f03579b5c247844f1c115c2be
ToppCell	TCGA-Skin-Metastatic-Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	BCAT1 SLA CXCR4 TLR4 C3AR1	1.63e-04	198	115	5	af4fb9eb2295c7b90624b38ba25619aa15254efa
ToppCell	critical-Myeloid\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	HCAR2 SLA HCAR3 CXCR4 C3AR1	1.63e-04	198	115	5	a5807517f8ca93b77f49f5787fd9036178b8fc2a
ToppCell	NS-critical-d_07-13-Myeloid\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	SLA HCAR3 CXCR4 TLR4 C3AR1	1.63e-04	198	115	5	08bc3f63a5c5b65bff10aadebdaa5e7f192cda01
ToppCell	10x3'2.3-week_17-19-Myeloid_neutrophil-granulo\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	HCAR2 SLA GSN HCAR3 C3AR1	1.63e-04	198	115	5	f870e398e996c1f28c8462d87b18f71b20c71011
ToppCell	TCGA-Skin-Metastatic\|TCGA-Skin / Sample_Type by Project: Shred V9	BCAT1 SLA CXCR4 TLR4 C3AR1	1.63e-04	198	115	5	ad39cce004867f083f8da1954e0cf5a263815184
ToppCell	5'-GW_trimst-2-SmallIntestine-Hematopoietic\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HCAR2 SLA HCAR3 CXCR4 C3AR1	1.63e-04	198	115	5	41e8a7894f52f3a5f8f24575b3f6e205429489b2
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	BCAT1 SLA CXCR4 TLR4 C3AR1	1.63e-04	198	115	5	62cbf4b29e8af4983fb47a17f96da62682a5137e
ToppCell	critical-Myeloid-Neutrophil\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	HCAR2 SLA HCAR3 CXCR4 C3AR1	1.63e-04	198	115	5	4da73dc3acb29d70b160903600d2bf7fdab34333
ToppCell	10x5'v1-week_14-16-Myeloid_neutrophil-granulo\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HCAR2 SLA HCAR3 CXCR4 C3AR1	1.67e-04	199	115	5	5919933c4b842b98fc98685dc8c72c8dd32c6ea3
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	UBR4 ARFGEF2 COLGALT1 SLA TLR4	1.67e-04	199	115	5	379bbd9cecf466b902411c54d74bd9885285b1ba
ToppCell	5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GSN PLEKHG1 MCF2L ACKR1 HYAL2	1.71e-04	200	115	5	9e44da8aaac239ed69d674dcd53800c5eaf397cb
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HAPLN2 KLHL32 ABCA8 GSN SLCO1A2	1.71e-04	200	115	5	acdef0b9096c774040948fc75621ff2b08ea2ee8
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	MYCBP2 NBEA TUBA1A CXCR4 MCF2L	1.71e-04	200	115	5	bad32a95b759fad509401b07bc96a56687c2a592
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HAPLN2 KLHL32 ABCA8 GSN SLCO1A2	1.71e-04	200	115	5	091a18d6efed81cab99955c3047f172170f70476
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HAPLN2 KLHL32 ABCA8 GSN SLCO1A2	1.71e-04	200	115	5	3b8513defe25262ab4b492345b2628570eaefd17
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABL1 BCAT1 ABCA8 GSN ANGPTL2	1.71e-04	200	115	5	10f0c20ba7c71d9e2e177597f85b41cb40f0d878
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HAPLN2 KLHL32 ABCA8 GSN SLCO1A2	1.71e-04	200	115	5	0bfd41c12887479ceb62c3db0a3c3ba5007eb62b
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HAPLN2 KLHL32 ABCA8 GSN SLCO1A2	1.71e-04	200	115	5	159377d904394d91e09913131e9a93e08189955a
ToppCell	ILEUM-non-inflamed-(7)_Endothelial_cell\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	GSN MGST2 MCF2L ACKR1 HYAL2	1.71e-04	200	115	5	ec92fe4eafe527d351ee73c9735e96855ac506a3
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HAPLN2 KLHL32 ABCA8 GSN SLCO1A2	1.71e-04	200	115	5	d30316836494f33ca46d4e415fd2ed179e9cb5ee
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABL1 BCAT1 ABCA8 GSN ANGPTL2	1.71e-04	200	115	5	a2bb67a06757f19be3f56f8cb5bb7e2affa5f4ed
Drug	NSC72302	TUBA1C TUBA3E CASR TUBA1A TUBAL3	1.79e-07	28	106	5	CID000118078
Drug	AC1L1IZ2	GALK2 TUBA1C MYO18A TUBA3E GSN MBTPS2 TUBA1A SLCO1A2 MYO3B LRBA TUBAL3	1.81e-07	304	106	11	CID000004795
Drug	Epothilone D	TUBA1C TUBA3C TUBA1B TUBA1A	2.13e-07	12	106	4	DB01873
Drug	Epothilone B	TUBA1C TUBA3C TUBA1B TUBA1A	2.13e-07	12	106	4	DB03010
Drug	2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE	TUBA1C TUBA1B TUBA1A	3.91e-07	4	106	3	DB07574
Drug	epo906	TUBA1C TUBA3E CASR TUBA1B TUBA1A TUBAL3 INVS	1.06e-06	114	106	7	CID000388945
Drug	bromocolchicine	TUBA1C TUBA3E TUBA1A TUBAL3	2.50e-06	21	106	4	CID000161518
Drug	Ustiloxin A	TUBA1C TUBA3E TUBA1A TUBAL3	2.50e-06	21	106	4	CID000164454
Drug	SRI-3072	TUBA1C TUBA3E TUBA1A TUBAL3	2.50e-06	21	106	4	CID000493469
Drug	colchifoline	TUBA1C TUBA3E TUBA1A TUBAL3	2.50e-06	21	106	4	CID000100132
Drug	3,4,5-trimethoxyacetophenone	TUBA1C TUBA3E TUBA1A TUBAL3	3.04e-06	22	106	4	CID000014345
Drug	AC1L1GIQ	TUBA1C TUBA3E TUBA1A TUBAL3	3.04e-06	22	106	4	CID000003700
Drug	2,4-dichlorobenzyl thiocyanate	TUBA1C TUBA3E TUBA1A TUBAL3	3.04e-06	22	106	4	CID000098538
Drug	SureCN13401588	TUBA1C TUBA3E TUBA1A TUBAL3	3.04e-06	22	106	4	CID009897422
Drug	N-methyldemecolcine	TUBA1C TUBA3E TUBA1A TUBAL3	3.04e-06	22	106	4	CID000023759
Drug	NSC-339672	TUBA1C TUBA3E TUBA1A TUBAL3	3.04e-06	22	106	4	CID000433930
Drug	IKP104	TUBA1C TUBA3E TUBA1A TUBAL3	3.67e-06	23	106	4	CID000130739
Drug	fluorescein-colchicine	TUBA1C TUBA3E TUBA1A TUBAL3	3.67e-06	23	106	4	CID003035871
Drug	3,4,5-trimethoxybenzaldehyde	TUBA1C TUBA3E TUBA1A TUBAL3	3.67e-06	23	106	4	CID000006858
Drug	3-demethylthiocolchicine	TUBA1C TUBA3E TUBA1A TUBAL3	3.67e-06	23	106	4	CID000084076
Drug	2,3,4-TCB	TUBA1C TUBA3E TUBA1A TUBAL3	3.67e-06	23	106	4	CID000129239
Drug	AC1L2P05	TUBA1C TUBA3E TUBA1A TUBAL3	3.67e-06	23	106	4	CID000125688
Drug	2,3,4-tabp	TUBA1C TUBA3E TUBA1A TUBAL3	3.67e-06	23	106	4	CID000125548
Drug	NSC-373301	TUBA1C TUBA3E TUBA1A TUBAL3	3.67e-06	23	106	4	CID000341375
Drug	N-acetylcolchinol	TUBA1C TUBA3E TUBA1A TUBAL3	3.67e-06	23	106	4	CID000097865
Drug	NSC355636	TUBA1C TUBA3E TUBA1A TUBAL3	3.67e-06	23	106	4	CID000100176
Drug	moscatilin	TUBA1C TUBA3E TUBA1A TUBAL3	4.39e-06	24	106	4	CID000176096
Drug	parbendazole	TUBA1C TUBA3E TUBA1A TUBAL3	4.39e-06	24	106	4	CID000026596
Drug	NSC-36768	TUBA1C TUBA3E TUBA1A TUBAL3	4.39e-06	24	106	4	CID000165441
Drug	deacetamidocolchicine	TUBA1C TUBA3E TUBA1A TUBAL3	4.39e-06	24	106	4	CID000014995
Drug	tropolone methyl ether	TUBA1C TUBA3E TUBA1A TUBAL3	4.39e-06	24	106	4	CID000016546
Drug	7-epi-cephalomannine	TUBA1C TUBA3E TUBA1A TUBAL3	4.39e-06	24	106	4	CID000330401
Drug	NABV	TUBA1C TUBA3E TUBA1A TUBAL3	4.39e-06	24	106	4	CID000175959
Drug	colchicide	TUBA1C TUBA3E TUBA1A TUBAL3	4.39e-06	24	106	4	CID000120712
Drug	AC1L4TG7	TUBA1C TUBA3E TUBA1A TUBAL3	4.39e-06	24	106	4	CID000163705
Drug	NBD-colcemid	TUBA1C TUBA3E TUBA1A TUBAL3	5.21e-06	25	106	4	CID000130594
Drug	mpMap	TUBA1C TUBA3E TUBA1A TUBAL3	5.21e-06	25	106	4	CID000100806
Drug	AC1Q6P06	TUBA1C TUBA3E TUBA1A TUBAL3	5.21e-06	25	106	4	CID000160263
Drug	2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone	TUBA1C TUBA3E TUBA1A TUBAL3	5.21e-06	25	106	4	CID000043264
Drug	allocolchicine	TUBA1C TUBA3E TUBA1A TUBAL3	5.21e-06	25	106	4	CID000196989
Drug	1069C85	TUBA1C TUBA3E TUBA1A TUBAL3	5.21e-06	25	106	4	CID006918099
Drug	55623-37-5	TUBA1C TUBA3E TUBA1A TUBAL3	5.21e-06	25	106	4	CID006438440
Drug	CA1P	TUBA1C TUBA3E TUBA1A TUBAL3	5.21e-06	25	106	4	CID006918545
Drug	peloruside A	TUBA1C TUBA3E TUBA1A TUBAL3	5.21e-06	25	106	4	CID006918506
Drug	NSC142227	TUBA1C TUBA3E TUBA1A TUBAL3	5.21e-06	25	106	4	CID000073427
Drug	MDL 27048	TUBA1C TUBA3E TUBA1A TUBAL3	5.21e-06	25	106	4	CID006439188
Drug	NSC527981	TUBA1C TUBA3E TUBA1A TUBAL3	6.13e-06	26	106	4	CID000352796
Drug	NSC332029	TUBA1C TUBA3E TUBA1A TUBAL3	6.13e-06	26	106	4	CID000100073
Drug	indibulin	TUBA1C TUBA3E TUBA1A TUBAL3	6.13e-06	26	106	4	CID000002929
Drug	pironetin	TUBA1C TUBA3E TUBA1A TUBAL3	6.13e-06	26	106	4	CID006438891
Drug	isaxonine	TUBA1C TUBA3E TUBA1A TUBAL3	6.13e-06	26	106	4	CID000071169
Drug	AC1L1J4H	TUBA1C TUBA3E TUBA1A TUBAL3	7.17e-06	27	106	4	CID000004862
Drug	NSC292222	TUBA1C TUBA3E TUBA1A TUBAL3	7.17e-06	27	106	4	CID000099957
Drug	dinitroanilines	TUBA1C TUBA3E TUBA1A TUBAL3	7.17e-06	27	106	4	CID000136400
Drug	NSC D-669356	TUBA1C TUBA3E TUBA1A TUBAL3	7.17e-06	27	106	4	CID000178028
Drug	NSC 370147	TUBA1C TUBA3E TUBA1A TUBAL3	8.34e-06	28	106	4	CID000182762
Drug	bp U	TUBA1C TUBA3E TUBA1A TUBAL3	9.64e-06	29	106	4	CID000368697
Drug	Aids106696	TUBA1C TUBA3E TUBA1A TUBAL3	9.64e-06	29	106	4	CID006475933
Drug	ddGDP	TUBA1C TUBA3E TUBA1A TUBAL3	9.64e-06	29	106	4	CID000134739
Drug	oxibendazole	TUBA1C TUBA3E TUBA1A TUBAL3	9.64e-06	29	106	4	CID000004622
Drug	AC1NBBHE	TUBA1C TUBA3E TUBA1A TUBAL3	1.11e-05	30	106	4	CID004490620
Drug	eleutherobin	TUBA1C TUBA3E TUBA1A TUBAL3	1.11e-05	30	106	4	CID006918335
Drug	azatoxin	TUBA1C TUBA3E TUBA1A TUBAL3	1.11e-05	30	106	4	CID000125383
Drug	NSC617668	TUBA1C TUBA3E TUBA1A TUBAL3	1.11e-05	30	106	4	CID000357989
Drug	citostal	TUBA1C TUBA3E TUBA1A TUBAL3	1.11e-05	30	106	4	CID000018991
Drug	thiocolchicine	TUBA1C TUBA3E TUBA1A TUBAL3	1.11e-05	30	106	4	CID000017648
Drug	tropone	TUBA1C TUBA3E TUBA1A TUBAL3	1.27e-05	31	106	4	CID000010881
Drug	NSC609395	TUBA1C TUBA3E TUBA1A TUBAL3	1.27e-05	31	106	4	CID005488798
Drug	amiprophosmethyl	TUBA1C TUBA3E TUBA1A TUBAL3	1.27e-05	31	106	4	CID000100524
Drug	AC7700	TUBA1C TUBA3E TUBA1A TUBAL3	1.27e-05	31	106	4	CID006918404
Drug	3,4-dimethylhexane-2,5-dione	TUBA1C TUBA3E TUBA1A TUBAL3	1.27e-05	31	106	4	CID000032851
Drug	AC1L3V8I	TUBA1C TUBA3E TUBA1A TUBAL3	1.27e-05	31	106	4	CID000122777
Drug	NSC332598	TUBA1C TUBA3E TUBA1A TUBAL3	1.27e-05	31	106	4	CID000615942
Drug	N,N'-ethylenebis(iodoacetamide	TUBA1C TUBA3E TUBA1A TUBAL3	1.27e-05	31	106	4	CID000023678
Drug	AC1L1G95	TUBA1C TUBA3E TUBA1A TUBAL3	1.44e-05	32	106	4	CID000003583
Drug	E2-3,4-Q	TUBA1C TUBA3E TUBA1A TUBAL3	1.44e-05	32	106	4	CID000067402
Drug	NSC153858	TUBA1C TUBA3E TUBA1A TUBAL3	1.44e-05	32	106	4	CID000547450
Drug	2-demethylcolchicine	TUBA1C TUBA3E TUBA1A TUBAL3	1.44e-05	32	106	4	CID000023757
Drug	CA4P	TUBA1C TUBA3E TUBA1A TUBAL3	1.64e-05	33	106	4	CID000370232
Drug	taltobulin	TUBA1C TUBA3E TUBA1A TUBAL3	1.64e-05	33	106	4	CID006918637
Drug	mebendazole	TUBA1C TUBA3E TUBA1A TUBAL3	1.64e-05	33	106	4	CID000004030
Drug	triethyllead	TUBA1C TUBA3E TUBA1A TUBAL3	1.85e-05	34	106	4	CID006328106
Drug	NSC376450	TUBA1C TUBA3E TUBA1A TUBAL3	1.85e-05	34	106	4	CID000005605
Drug	2-phenyl-4-quinolone	TUBA1C TUBA3E TUBA1A TUBAL3	1.85e-05	34	106	4	CID000161091
Drug	H-Mn	HCAR2 TUBA1C TUBA1B HCAR3 TUBA1A	2.03e-05	71	106	5	CID000445522
Drug	discodermolide	TUBA1C TUBA3E TUBA1A TUBAL3	2.08e-05	35	106	4	CID000643668
Drug	desglucocheirotoxin	CASR TNK2	2.15e-05	2	106	2	CID000002862
Drug	AC1O5Y0F	TUBA1C TUBA3E TUBA1A TUBAL3	2.60e-05	37	106	4	CID006442852
Drug	DTAF	TUBA1C TUBA3E TUBA1A TUBAL3	2.60e-05	37	106	4	CID000123934
Drug	albendazole	TUBA1C TUBA3E TUBA1A TUBAL3	2.60e-05	37	106	4	CID000002082
Drug	baccatin III	TUBA1C TUBA3E TUBA1A TUBAL3	2.60e-05	37	106	4	CID000065366
Drug	laulimalide	TUBA1C TUBA3E TUBA1A TUBAL3	2.90e-05	38	106	4	CID006918457
Drug	gnoscopine	TUBA1C TUBA3E TUBA1A TUBAL3	2.90e-05	38	106	4	CID000004544
Drug	colchiceine	TUBA1C TUBA3E TUBA1A TUBAL3	2.90e-05	38	106	4	CID000010156
Drug	vinblastine	HCAR2 TUBA1C TUBA3E TUBA1B HCAR3 TUBA1A TUBAL3	2.96e-05	189	106	7	CID000013342
Drug	NF T	TUBA1C TUBA3E CYP46A1 FANCD2 MMEL1 TUBA1A TUBAL3	3.06e-05	190	106	7	CID006436102
Drug	colcemid; Up 200; 11.7uM; MCF7; HT_HG-U133A_EA	ABL1 ZMYND8 ARFGEF1 F2RL1 KATNIP DNMBP HYAL2	3.06e-05	190	106	7	1103_UP
Drug	erianin	TUBA1C TUBA3E TUBA1A TUBAL3	3.22e-05	39	106	4	CID000356759
Drug	Dolastatin 10	TUBA1C TUBA3E TUBA1A TUBAL3	3.22e-05	39	106	4	CID000100208
Drug	trifluralin	TUBA1C TUBA3E SLA TUBA1A HERC1 TUBAL3	3.45e-05	131	106	6	CID000005569
Disease	primary ovarian insufficiency (implicated_via_orthology)	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	9.96e-28	46	116	16	DOID:5426 (implicated_via_orthology)
Disease	congenital heart disease (implicated_via_orthology)	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.79e-24	69	116	16	DOID:1682 (implicated_via_orthology)
Disease	microlissencephaly (implicated_via_orthology)	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A	9.01e-14	8	116	6	DOID:0112234 (implicated_via_orthology)
Disease	lissencephaly 3 (implicated_via_orthology)	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A	9.01e-14	8	116	6	DOID:0112232 (implicated_via_orthology)
Disease	polymicrogyria (implicated_via_orthology)	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A	9.01e-14	8	116	6	DOID:0080918 (implicated_via_orthology)
Disease	lissencephaly (implicated_via_orthology)	TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A	8.96e-10	27	116	6	DOID:0050453 (implicated_via_orthology)
Disease	lung disease (biomarker_via_orthology)	F2RL1 GSN TLR4 C3AR1	1.08e-05	35	116	4	DOID:850 (biomarker_via_orthology)
Disease	respiratory allergy (is_implicated_in)	F2RL1 TLR4	1.52e-04	5	116	2	DOID:0060496 (is_implicated_in)
Disease	Acute Coronary Syndrome	TUBA1C GSN TLR4	2.96e-04	33	116	3	C0948089
Disease	coronary aneurysm	TUBA3C MYO3B MAN1B1	3.53e-04	35	116	3	EFO_1000881
Disease	outer ear morphology trait	MYO3B LRBA	9.86e-04	12	116	2	EFO_0007664
Disease	FVC change measurement, response to placebo	DGKB KATNIP	1.16e-03	13	116	2	EFO_0008344, EFO_0010339
Disease	Congenital total cataract	LIM2 DNMBP	1.77e-03	16	116	2	C0266539
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	HCAR2 TMEM116 ABCA8 HCAR3 LRBA	1.99e-03	225	116	5	EFO_0008317, EFO_0020947
Disease	erythrocyte cadmium measurement	XKR9 BCAT1	2.00e-03	17	116	2	EFO_0007807
Disease	melanoma	ABL1 UBR4 CUBN F2RL1 TLR4	3.03e-03	248	116	5	C0025202
Disease	skin hydration measurement	PKD1L1 PLEKHG1	3.06e-03	21	116	2	EFO_0009586

Protein segments in the cluster

Peptide	Gene	Start	Entry
IIAFFAHLACNEGNW	EP400	1126	Q96L91
LAHRGGYWTLLQNCC	CFAP54	1626	Q96N23
GCQQVLWLYGEDHQI	BCAT1	241	P54687
NWYFGNFLCKAVHVI	CXCR4	101	P61073
LLCLQGNYAGHDWFV	TBC1D32	1056	Q96NH3
DGNYLGNSWHEILKC	ARFGEF1	1036	Q9Y6D6
ECGDLVGNYSIINWH	CASR	481	P41180
DGNYLGNSWHEILKC	ARFGEF2	981	Q9Y6D5
WYGSAFAQALLLGCH	ACKR1	136	Q16570
EWGCTNYINLGSFLI	DNMBP	906	Q6XZF7
NACAHSNLNGVWYRG	ANGPTL2	441	Q9UKU9
YGGDLHSALDWLCLN	DHX29	151	Q7Z478
HLALQGQWPYGRFLC	C3AR1	81	Q16581
FDWNLEQAGCHLLGS	TNK2	1016	Q07912
WAKCHNIYSNILGFL	PAPOLB	231	Q9NRJ5
LQTHFRCQCYLGWSG	HYAL2	421	Q12891
SFAHQGLWRYCLGNK	LIM2	36	P55344
CFGWYALHFLVQSGI	MBOAT2	71	Q6ZWT7
GHLYAAWKFSGLDQC	HAPLN2	276	Q9GZV7
GLLGNGLALWIFCFH	HCAR2	41	Q8TDS4
QYANAAHGYNWGLRC	GALNT9	286	Q9HCQ5
NWFHLIGITCGLAIY	HERC3	786	Q15034
CLQLNFTASWGDLHY	KATNIP	1211	O60303
KCDVYLWGAGRHGQL	HERC1	3996	Q15751
HSLCGDLLLGRWGNY	PCNX1	1566	Q96RV3
ACWFILAAIYHLGAA	MYO18A	661	Q92614
ACKAYITDGGLNHVW	DNAH8	296	Q96JB1
LWHNYFLCGLKGIQE	GALK2	106	Q01415
VSCQLHQWIDLIFGY	LRBA	2416	P50851
ALWHGLHSGYLVCFQ	LPCAT3	371	Q6P1A2
LQYCDFLGSGAAIWV	PGAP6	606	Q9HCN3
GLHVCGGSILNEYWV	PRSS38	81	A1L453
HEQLFFINYAQVWCG	MMEL1	711	Q495T6
WQVSLRYDGAHLCGG	HPN	176	P05981
NGILQIGWSDFHNCL	LRRC66	181	Q68CR7
DCNFLISHLYWNCGL	LRRIQ1	951	Q96JM4
CGLLFYINLADHWKA	MAN1B1	96	Q9UKM7
AYHLNGNNWVFGEVL	F2RL2	151	O00254
VNGFQLLYVGDALWH	TM7SF2	226	O76062
GFGAQHEFWCILFIV	OR5AK2	16	Q8NH90
IHGNNWIYGEALCNV	F2RL1	136	P55085
LFCEWHLQGLSGHYL	CUBN	2361	O60494
QTFVFCYLWSLGGNL	DNAH6	1991	Q9C0G6
LSGHNYLCPNDWLLN	KLRF2	71	D3W0D1
CLWFIGHITQFYGII	CPB2	191	Q96IY4
FGQGLVSECNYERWH	CYP46A1	121	Q9Y6A2
NCWNVIHYSGFLHLE	EPM2AIP1	271	Q7L775
LGEEFCHWFFGLLNS	C3orf38	141	Q5JPI3
WLAQRFHCQNGCILG	CHD1L	56	Q86WJ1
HQRAICVYGAGDLNW	GCNT3	386	O95395
CVYGAGDLNWMLQNH	GCNT3	391	O95395
YQGLTGLHCVWCQIT	DGKB	331	Q9Y6T7
IGNQWILTAAHCFYG	F11	421	P03951
EKLRVLGYNHNGEWC	ABL1	86	P00519
SQQFHCIWKLLYAGA	ASB5	211	Q8WWX0
LGGTLDYCHSRWLCQ	MCF2L	216	O15068
FCAGIWHNFVLALLG	MBTPS2	221	O43462
WQAGLFHLTRLFCGA	KLK9	36	Q9UKQ9
GHRTCLWNDQLYLVG	KLHDC9	316	Q8NEP7
GNLQYDLHYWLGNEC	GSN	106	P06396
FILDLGNNIHQWCGS	GSN	216	P06396
VLGAICWYVHQAGEL	FLRT1	541	Q9NZU1
TKGELGCFLSHYNIW	COLGALT1	406	Q8NBJ5
WDDINNVGLRGHYFC	DHRS1	116	Q96LJ7
DAKWILHNCIIYNGG	ZMYND8	216	Q9ULU4
AYRFGQEQCVQWLHL	PKD1L1	2156	Q8TDX9
SGLWHLGLTATNYNC	CNTNAP5	16	Q8WYK1
CYQRLLQIFHGLFAW	FANCD2	1061	Q9BXW9
FHLELITLYGNLWNC	LRRC19	166	Q9H756
TALHWSCNNGYLDAI	INVS	491	Q9Y283
GWYFNQVFATCLGLV	MGST2	71	Q99735
YSGWALCAEGFLLNN	NNT	841	Q13423
CVARVYHGWLFEGLG	SLA	76	Q13239
FLWGCNLLAHFINAY	MTCH1	266	Q9NZJ7
LSQDELWGLHRLYGC	MMP23B	241	O75900
GLLGNGLALWIFCFH	HCAR3	41	P49019
SCQLHQWIDLIFGYK	NBEA	2491	Q8NFP9
GGNNHWVYVALFICA	SLCO5A1	256	Q9H2Y9
GYTEAWCLSFNQHLG	MYCBP2	2531	O75592
YGWEVHQLALGGLCY	TECTB	46	Q96PL2
WELYCLEHGIQPNGV	TUBAL3	21	A6NHL2
QAAHIGCWLSLLEYL	SLCO1A2	386	P46721
SLCNGLIAAQLLFYW	MPDU1	221	O75352
DHGCSRWGYFFLQNA	SLC39A6	716	Q13433
WGIGYHLSLQLNEIC	ABCA8	706	O94911
WANHLFLGCSYNKDL	CDKN2AIPNL	71	Q96HQ2
IGNACWELYCLEHGI	TUBA3D	16	P0DPH8
LYLGGEWQFNHFSKL	USP17L3	6	A6NCW0
LYLGGEWQFNHFSKL	USP17L4	6	A6NCW7
AGALFVHICLGWNFY	SLC5A10	156	A0PJK1
YQIWCLGNESRFHLN	ROBO3	806	Q96MS0
WHYIGICGGFAFILL	SERINC4	181	A6NH21
IGNACWELYCLEHGI	TUBA3C	16	P0DPH7
LYLGGEWQFNHFSKL	USP17L18	6	D6R9N7
LLNCGVYGWTQHKFH	TMEM116	186	Q8NCL8
LYLGGEWQFNHFSKL	USP17L21	6	D6R901
LYLGGEWQFNHFSKL	USP17L13	6	C9JLJ4
LYLGGEWQFNHFSKL	USP17L19	6	D6RCP7
LYLGGEWQFNHFSKL	USP17L1	6	Q7RTZ2
LYLGGEWQFNHFSKL	USP17L12	6	C9JPN9
WAFLDGLIEAGYHCE	ZNF462	1301	Q96JM2
LYLGGEWQFNHFSKL	USP17L8	6	P0C7I0
IGNACWELYCLEHGI	TUBA1A	16	Q71U36
IGNACWELYCLEHGI	TUBA3E	16	Q6PEY2
NWCQDHLYNSLGRKG	PLEKHG1	1156	Q9ULL1
YSGDGQWLACGLANH	WDR27	521	A2RRH5
IGNACWELYCLEHGI	TUBA1B	16	P68363
LYLGGEWQFNHFSKL	USP17L22	6	D6RA61
EHYQNFQLLGAWCLL	UBR4	401	Q5T4S7
FSYNFGWQHLELVNC	TLR4	326	O00206
LYLGGEWQFNHFSKL	USP17L15	6	C9J2P7
LYLGGEWQFNHFSKL	USP17L17	6	D6RBQ6
IGNACWELYCLEHGI	TUBA1C	16	Q9BQE3
LYLGGEWQFNHFSKL	USP17L23	6	D6RBM5
LYLGGEWQFNHFSKL	USP17L2	6	Q6R6M4
LYLGGEWQFNHFSKL	USP17L20	6	D6RJB6
LYLGGEWQFNHFSKL	USP17L10	6	C9JJH3
LHCLQGGVFTRYWFA	XKR9	81	Q5GH70
GKAFCWGYQLTRHQI	ZNF283	381	Q8N7M2
LYLGGEWQFNHFSKL	USP17L11	6	C9JVI0
LSCHAGYVADGLLWI	KLHL32	436	Q96NJ5
NALWDLVQFAYTGCL	KLHL1	261	Q9NR64
MSIFNNGWNLGYLHC	MTNR1A	86	P48039
NGWNLGYLHCQVSGF	MTNR1A	91	P48039
FYKADHCVGGQLWLV	MYO3B	91	Q8WXR4